Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Maravai Lifesciences Holdings (MRVI) Accumulated Depreciation & Amortization (2020 - 2025)

Maravai Lifesciences Holdings has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at -$69.4 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at -$69.4 million for Q4 2025, up 45.29% from a year ago — trailing twelve months through Dec 2025 was -$69.4 million (up 45.29% YoY), and the annual figure for FY2025 was -$69.4 million, up 45.29%.
  • Accumulated Depreciation & Amortization for Q4 2025 was -$69.4 million at Maravai Lifesciences Holdings, up from -$126.9 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for MRVI hit a ceiling of -$15.3 million in Q4 2021 and a floor of -$126.9 million in Q4 2024.
  • Median Accumulated Depreciation & Amortization over the past 5 years was -$69.4 million (2025), compared with a mean of -$75.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 84.53% in 2021 and later crashed 225.47% in 2022.
  • Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization stood at -$15.3 million in 2021, then crashed by 225.47% to -$49.7 million in 2022, then crashed by 129.64% to -$114.1 million in 2023, then decreased by 11.2% to -$126.9 million in 2024, then soared by 45.29% to -$69.4 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were -$69.4 million (Q4 2025), -$126.9 million (Q4 2024), and -$114.1 million (Q4 2023) per Business Quant data.